John Docherty - Sep 1, 2021 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Role
President, Director
Signature
/John Docherty/
Stock symbol
LEXX
Transactions as of
Sep 1, 2021
Transactions value $
$0
Form type
4
Date filed
9/2/2021, 01:49 PM
Previous filing
Jun 9, 2021
Next filing
Aug 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding LEXX common shares 54.1K Sep 1, 2021 Private Holding Company

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LEXX Stock Options Award $0 +15K +30.2% $0.00 64.7K Sep 1, 2021 Common Shares 15K $6.23 Direct
holding LEXX Stock Options 13.3K Sep 1, 2021 Common Shares 13.3K $9.60 Direct
holding LEXX Stock Options 31.3K Sep 1, 2021 Common Shares 18K $5.31 Direct
holding LEXX Stock Options 49.7K Sep 1, 2021 Common Shares 18.3K $7.08 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.